流感疫苗接种减轻体外循环冠状动脉旁路移植术后炎症反应
结果显示疫苗接种组促炎细胞因子(白介素-6、白介素-8、肿瘤坏死因子)水平显著降低,抗炎因子白介素-10显著升高,术后肌钙蛋白有降低趋势,提示流感疫苗接种可能减轻体外循环相关炎症反应并改善心肌保护。
要点
- 术前流感疫苗接种可降低体外循环术后促炎因子水平
- 疫苗接种组抗炎因子白介素-10水平显著升高
- 术后肌钙蛋白在疫苗组有降低趋势,提示心肌保护改善
核心结论
- 流感疫苗接种可减轻体外循环冠状动脉旁路移植术后的炎症反应,表现为促炎介质降低、抗炎因子白介素-10升高及肌钙蛋白降低趋势。
主要发现
- 疫苗组促炎细胞因子水平显著低于安慰剂组:白介素-6为157.4 pg/dL vs 256 pg/dL(P=.043),白介素-8为65.03 pg/dL vs 118.56 pg/dL(P=.025),肿瘤坏死因子为12.05 pg/dL vs 20.8 pg/dL(P=.003)。
- 上述差异在体外循环结束时即出现,并持续至术后2天。
- 疫苗组抗炎标志物白介素-10水平显著高于安慰剂组(83.3 pg/dL vs 15.15 pg/dL,P=.008)。
- 疫苗组术后肌钙蛋白有降低趋势(6020.2 pg/dL vs 12,098.01 pg/dL,P=.052),提示心肌保护改善。
临床怎么用
- 对于拟行体外循环冠状动脉旁路移植术的患者,术前接种流感疫苗可能有助于减轻围术期炎症反应并改善心肌保护,但需更多研究验证临床获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Coronary artery bypass grafting with cardiopulmonary bypass (CPB) induces an inflammatory reaction that is associated with postoperative complications. Influenza vaccination has been shown to decrease cardiovascular morbidity in patients with cardiovascular disease, possibly via its anti-inflammatory properties. We hypothesize that influenza vaccination would attenuate the inflammatory reaction after CPB. METHODS: Thirty patients undergoing coronary artery bypass grafting were blindly randomized to receive the influenza vaccine (group I, n = 15) or a placebo (group II, n = 15) preoperatively. Serum samples of proinflammatory mediators (interleukin-6, interleukin-8, tumor necrosis factor, C-reactive protein) as well as the anti-inflammatory interleukin-10 were collected at different time points perioperatively. Assessment of myocardial dysfunction was investigated by measuring hemodynamic data, echocardiographic data, and troponin levels. Other clinical outcomes were collected prospectively. RESULTS: Proinflammatory cytokine levels were significantly reduced in the treatment group vs the placebo group (interleukin-6 [157.4 pg/dL vs 256 pg/dL, P = .043], interleukin-8 [65.03 pg/dL vs 118.56 pg/dL, P = .025], and tumor necrosis factor [12.05 pg/dL vs 20.8 pg/dL, P = .003]). These differences were observed at the end of CPB and persisted for 2 days postoperatively. Interestingly, the level of the anti-inflammatory marker interleukin-10 was significantly higher in group I (83.3 pg/dL vs 15.15 pg/dL, P = .008). Evidence of improved myocardial protection was observed in group I, as reflected by troponin measurements postoperatively (6020.2 pg/dL vs 12,098.01 pg/dL, P = .052). CONCLUSIONS: Influenza vaccination attenuates the inflammatory response to CPB as reflected by a reduction in the level of troponin and proinflammatory mediators and an increase in the anti-inflammatory cytokine interleukin-10.
引用
- Atoui R, Ebrahim F, Saroka K, et al. Influenza Vaccination Blunts the Inflammatory Response in Patients Undergoing Cardiopulmonary Bypass. Ann Thorac Surg. 2020. PMID: 33038338. doi:10.1016/j.athoracsur.2020.07.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。